These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 24835816)
1. B-ring modified aurones as promising allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase. Meguellati A; Ahmed-Belkacem A; Yi W; Haudecoeur R; Crouillère M; Brillet R; Pawlotsky JM; Boumendjel A; Peuchmaur M Eur J Med Chem; 2014 Jun; 80():579-92. PubMed ID: 24835816 [TBL] [Abstract][Full Text] [Related]
2. New pseudodimeric aurones as palm pocket inhibitors of Hepatitis C virus RNA-dependent RNA polymerase. Meguellati A; Ahmed-Belkacem A; Nurisso A; Yi W; Brillet R; Berqouch N; Chavoutier L; Fortuné A; Pawlotsky JM; Boumendjel A; Peuchmaur M Eur J Med Chem; 2016 Jun; 115():217-29. PubMed ID: 27017550 [TBL] [Abstract][Full Text] [Related]
3. Discovery of naturally occurring aurones that are potent allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase. Haudecoeur R; Ahmed-Belkacem A; Yi W; Fortuné A; Brillet R; Belle C; Nicolle E; Pallier C; Pawlotsky JM; Boumendjel A J Med Chem; 2011 Aug; 54(15):5395-402. PubMed ID: 21699179 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships in the development of allosteric hepatitis C virus RNA-dependent RNA polymerase inhibitors: ten years of research. Haudecoeur R; Peuchmaur M; Ahmed-Belkacem A; Pawlotsky JM; Boumendjel A Med Res Rev; 2013 Sep; 33(5):934-84. PubMed ID: 22893620 [TBL] [Abstract][Full Text] [Related]
5. Anti-hepatitis C virus RdRp activity and replication of novel anilinobenzothiazole derivatives. Peng HK; Chen WC; Lin YT; Tseng CK; Yang SY; Tzeng CC; Lee JC; Yang SC Antiviral Res; 2013 Oct; 100(1):269-75. PubMed ID: 23994188 [TBL] [Abstract][Full Text] [Related]
6. A fluorescence-based high-throughput screen to identify small compound inhibitors of the genotype 3a hepatitis C virus RNA polymerase. Eltahla AA; Lackovic K; Marquis C; Eden JS; White PA J Biomol Screen; 2013 Oct; 18(9):1027-34. PubMed ID: 23708123 [TBL] [Abstract][Full Text] [Related]
7. Substituted 2,6-bis(benzimidazol-2-yl)pyridines: a novel chemical class of pestivirus inhibitors that targets a hot spot for inhibition of pestivirus replication in the RNA-dependent RNA polymerase. Musiu S; Pürstinger G; Stallinger S; Vrancken R; Haegeman A; Koenen F; Leyssen P; Froeyen M; Neyts J; Paeshuyse J Antiviral Res; 2014 Jun; 106():71-9. PubMed ID: 24680957 [TBL] [Abstract][Full Text] [Related]
11. Simple but highly effective three-dimensional chemical-feature-based pharmacophore model for diketo acid derivatives as hepatitis C virus RNA-dependent RNA polymerase inhibitors. Di Santo R; Fermeglia M; Ferrone M; Paneni MS; Costi R; Artico M; Roux A; Gabriele M; Tardif KD; Siddiqui A; Pricl S J Med Chem; 2005 Oct; 48(20):6304-14. PubMed ID: 16190757 [TBL] [Abstract][Full Text] [Related]
12. Identification of novel HCV RNA-dependent RNA polymerase inhibitors using pharmacophore-guided virtual screening. Kim J; Kim KS; Kim DE; Chong Y Chem Biol Drug Des; 2008 Dec; 72(6):585-91. PubMed ID: 19090925 [TBL] [Abstract][Full Text] [Related]
13. Identification of a novel resistance mutation for benzimidazole inhibitors of the HCV RNA-dependent RNA polymerase. Delang L; Froeyen M; Herdewijn P; Neyts J Antiviral Res; 2012 Jan; 93(1):30-8. PubMed ID: 22033247 [TBL] [Abstract][Full Text] [Related]
14. RNA dependent RNA polymerase of HCV: a potential target for the development of antiviral drugs. Waheed Y; Bhatti A; Ashraf M Infect Genet Evol; 2013 Mar; 14():247-57. PubMed ID: 23291407 [TBL] [Abstract][Full Text] [Related]
15. Optimization of novel acyl pyrrolidine inhibitors of hepatitis C virus RNA-dependent RNA polymerase leading to a development candidate. Slater MJ; Amphlett EM; Andrews DM; Bravi G; Burton G; Cheasty AG; Corfield JA; Ellis MR; Fenwick RH; Fernandes S; Guidetti R; Haigh D; Hartley CD; Howes PD; Jackson DL; Jarvest RL; Lovegrove VL; Medhurst KJ; Parry NR; Price H; Shah P; Singh OM; Stocker R; Thommes P; Wilkinson C; Wonacott A J Med Chem; 2007 Mar; 50(5):897-900. PubMed ID: 17269759 [TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism of a thumb domain hepatitis C virus nonnucleoside RNA-dependent RNA polymerase inhibitor. Howe AY; Cheng H; Thompson I; Chunduru SK; Herrmann S; O'Connell J; Agarwal A; Chopra R; Del Vecchio AM Antimicrob Agents Chemother; 2006 Dec; 50(12):4103-13. PubMed ID: 16940072 [TBL] [Abstract][Full Text] [Related]
19. Efficient in silico assay of inhibitors of hepatitis C Virus RNA-dependent RNA polymerase by structure-based virtual screening and in vitro evaluation. Lin YT; Huang KJ; Tseng CK; Chen KJ; Wang HM; Lee JC Assay Drug Dev Technol; 2011 Jun; 9(3):290-8. PubMed ID: 21281131 [TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus-reverse transcriptase inhibition and hepatitis C virus RNA-dependent RNA polymerase inhibition activities of fullerene derivatives. Mashino T; Shimotohno K; Ikegami N; Nishikawa D; Okuda K; Takahashi K; Nakamura S; Mochizuki M Bioorg Med Chem Lett; 2005 Feb; 15(4):1107-9. PubMed ID: 15686922 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]